"Leukemia, Myeloid, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Concept/Terms
Leukemia, Myeloid, Acute- Leukemia, Myeloid, Acute
- ANLL
- Leukemia, Myeloblastic, Acute
- Leukemia, Myelocytic, Acute
- Leukemia, Myelogenous, Acute
- Nonlymphocytic Leukemia, Acute
- Acute Nonlymphocytic Leukemia
- Acute Nonlymphocytic Leukemias
- Leukemia, Acute Nonlymphocytic
- Leukemias, Acute Nonlymphocytic
- Nonlymphocytic Leukemias, Acute
- Leukemia, Nonlymphocytic, Acute
- Myeloblastic Leukemia, Acute
- Acute Myeloblastic Leukemia
- Acute Myeloblastic Leukemias
- Leukemia, Acute Myeloblastic
- Leukemias, Acute Myeloblastic
- Myeloblastic Leukemias, Acute
- Myelocytic Leukemia, Acute
- Acute Myelocytic Leukemia
- Acute Myelocytic Leukemias
- Leukemia, Acute Myelocytic
- Leukemias, Acute Myelocytic
- Myelocytic Leukemias, Acute
- Myelogenous Leukemia, Acute
- Acute Myelogenous Leukemia
- Acute Myelogenous Leukemias
- Leukemia, Acute Myelogenous
- Leukemias, Acute Myelogenous
- Myelogenous Leukemias, Acute
- Myeloid Leukemia, Acute
- Nonlymphoblastic Leukemia, Acute
- Acute Nonlymphoblastic Leukemia
- Acute Nonlymphoblastic Leukemias
- Leukemia, Acute Nonlymphoblastic
- Leukemias, Acute Nonlymphoblastic
- Nonlymphoblastic Leukemias, Acute
- Acute Myeloid Leukemia
- Acute Myeloid Leukemias
- Leukemia, Acute Myeloid
- Leukemias, Acute Myeloid
- Myeloid Leukemias, Acute
- Leukemia, Nonlymphoblastic, Acute
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid, Acute".
- Leukemia, Myeloid, Acute
- Leukemia, Basophilic, Acute
- Leukemia, Eosinophilic, Acute
- Leukemia, Erythroblastic, Acute
- Leukemia, Mast-Cell
- Leukemia, Megakaryoblastic, Acute
- Leukemia, Monocytic, Acute
- Leukemia, Promyelocytic, Acute
This graph shows the total number of publications written about "Leukemia, Myeloid, Acute" by people in Harvard Catalyst Profiles by year, and whether "Leukemia, Myeloid, Acute" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 6 | 2 | 8 |
| 1992 | 15 | 3 | 18 |
| 1993 | 3 | 1 | 4 |
| 1994 | 8 | 3 | 11 |
| 1995 | 8 | 2 | 10 |
| 1996 | 5 | 1 | 6 |
| 1997 | 7 | 3 | 10 |
| 1998 | 5 | 0 | 5 |
| 1999 | 4 | 1 | 5 |
| 2000 | 7 | 1 | 8 |
| 2001 | 9 | 2 | 11 |
| 2002 | 10 | 3 | 13 |
| 2003 | 15 | 1 | 16 |
| 2004 | 9 | 3 | 12 |
| 2005 | 13 | 2 | 15 |
| 2006 | 16 | 2 | 18 |
| 2007 | 20 | 3 | 23 |
| 2008 | 27 | 13 | 40 |
| 2009 | 39 | 7 | 46 |
| 2010 | 60 | 9 | 69 |
| 2011 | 50 | 7 | 57 |
| 2012 | 68 | 6 | 74 |
| 2013 | 66 | 6 | 72 |
| 2014 | 71 | 10 | 81 |
| 2015 | 77 | 13 | 90 |
| 2016 | 98 | 17 | 115 |
| 2017 | 103 | 12 | 115 |
| 2018 | 114 | 14 | 128 |
| 2019 | 91 | 6 | 97 |
| 2020 | 56 | 2 | 58 |
| 2021 | 2 | 1 | 3 |
Below are the most recent publications written about "Leukemia, Myeloid, Acute" by people in Profiles.
-
Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2. Am J Clin Pathol. 2021 02 04; 155(2):160-178.
-
Hospitalizations in long-term survivors of childhood AML treated with allogeneic HCT-An Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study. Am J Hematol. 2021 03 01; 96(3):E74-E77.
-
Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML. Nat Commun. 2021 01 11; 12(1):245.
-
Transfusion-related Iron Overload in Children With Leukemia. J Pediatr Hematol Oncol. 2021 01; 43(1):18-23.
-
Trends and outcomes of venous thromboembolism in adult hospitalizations with acute myeloid leukemia: analysis of nationwide inpatient sample from 2010 to 2014. Postgrad Med. 2021 Mar; 133(2):160-165.
-
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype. Blood. 2020 12 10; 136(24):2812-2823.
-
Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia. Am J Hematol. 2021 03 01; 96(3):E59-E63.
-
Does patient fitness play a role in determining first-line treatment of acute myeloid leukemia? Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):41-50.
-
Informed consent for genetic testing in hematology. Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):213-218.
-
A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia. Nat Commun. 2020 11 26; 11(1):5998.